Overview

A Non-inferiority, Multicenter and Randomized, Single-Dose Study About a Treatment to Hypolactasia (LAILAI)

Status:
Completed

Trial end date:
2012-03-01

Target enrollment:

Participant gender:

Summary

The study primary objective is to compare the clinical efficacy of two formulations in the supportive treatment of lactose intolerance.

Phase:

Phase 3

Details

Lead Sponsor:

Eurofarma Laboratorios S.A.